Ideal candidates have significant central or visceral fat, often with metabolic risk factors, and are ready to commit to daily injections, lab monitoring, and lifestyle changes
Baseline: CBC, B12, folate, iron studies Repeat B12 levels 1 month after loading dose Annual checks for chronic therapy Monitor potassium during initial treatment Neurological exams for neuropathic symptoms B12 injections can "mask" megaloblastic anemia from folate deficiency while allowing neurological damage to progress
Protocol Details Tesamorelin is administered as a daily subcutaneous injection, typically in the abdominal area
Before treatment, ask the prescribing provider and dispensing pharmacy about: The exact formulation and inactive ingredients Injection route and prescribed dose Storage requirements Potential adverse effects and relevant medical conditions Possible medication or supplement interactions Instructions for responding to a reaction Complete medical, allergy, medication, supplement, pregnancy, and prior injection-reaction histories should be disclosed during evaluation